These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32757000)

  • 1. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
    Liu Y; Xia C; Chen J; Fan C; He J
    Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of low density granulocytes and NETosis in the pathogenesis of adult-onset Still's Disease.
    Torres-Ruiz J; Carrillo-Vázquez DA; Tapia-Rodríguez M; Garcia-Galicia JA; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):74-82. PubMed ID: 31365336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
    Liu Y; Zhang S; Xia CS; Chen J; Fan C
    J Rheumatol; 2021 May; 48(5):664-668. PubMed ID: 32934126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
    Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
    Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
    J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
    Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.
    Chi H; Hong X; Dai N; Chen L; Zhang H; Liu H; Cheng X; Ye J; Shi H; Hu Q; Meng J; Zhou Z; Jia J; Liu T; Wang F; Wang M; Ma Y; Chen X; You Y; Zhu D; Tang Z; Yang C; Teng J; Su Y; Sun Y
    Rheumatology (Oxford); 2024 Jul; 63(7):1987-1997. PubMed ID: 37756690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
    Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
    Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
    Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
    Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
    Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.
    Liao TL; Chen YM; Hsieh CW; Chen HH; Lee HC; Hung WT; Tang KT; Chen DY
    Sci Rep; 2017 Jun; 7(1):4214. PubMed ID: 28646209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
    Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
    Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
    Navarini L; Vomero M; Currado D; Berardicurti O; Biaggi A; Marino A; Bearzi P; Corberi E; Rigon A; Arcarese L; Leuti A; Fava M; Fogolari M; Mattei A; Ruscitti P; Di Cola I; Sambuco F; Travaglino F; Angeletti S; Ursini F; Mariani E; Cipriani P; Agrò FE; Iagnocco A; Antonelli Incalzi R; Maccarrone M; Giacomelli R
    Front Immunol; 2023; 14():1148268. PubMed ID: 37153620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.